Metrics as of 10/15/2026, 06:28 PM (Berlin time), refresh in progress.
Certara Stock
Certara, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Jon Resnick
- Employees
- 1,546
- Market cap
- $1.5 B
- IPO
- 11/12/2020
Certara, Inc. is a healthcare company operating within the medical, healthcare information services industry. Headquartered in Radnor, the company provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. Its operations span…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Certara stock: price history
1D
+2.9%
1W
+11.5%
1M
+14.7%
6M
+56.4%
YTD
+9.3%
1Y
-19.5%
2Y
-14.1%
5Y
-74.5%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~66% stronger price swings than usual
Ask the agents about Certara
Analyst assessment of Certara
PRICE TARGET LOW
US$7.50
CONSENSUS
US$8.50
MEDIAN
US$8.00
PRICE TARGET HIGH
US$10.00
0
STRONG BUY
8
BUY
9
HOLD
0
SELL
0
STRONG SELL
17
TOTAL · Hold
As of: 13/10/2026
Certara stock metrics
P/E
-21.73
P/B
1.54
EV/EBITDA
15.48
RETURN ON EQUITY
-5.7%
NET MARGIN
-59.3%
DEBT/EQUITY
0.3
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.4%
FLOAT SHARES
111,952,787
AVG. DAILY VOLUME (30D)
2,744,098
Insider transactions (SEC)
Anhalt Rona
Anhalt Rona
Corcoran Daniel
Corcoran Daniel
Corcoran Daniel
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.9%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Certara stock
What does Certara do?
Certara, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Jon Resnick, the company employs around 1,546 people.
The IPO was on 11/12/2020; the stock trades on NASDAQ under the ticker CERT.
What do analysts say about Certara stock?
17 analysts rate the stock, the consensus is Hold (as of 13/10/2026).
The average price target is US$8.50, ranging from US$7.50 to US$10.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does Certara report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 66% stronger than usual.
Does Certara pay a dividend?
No, Certara currently does not pay a dividend.
Which stocks are comparable to Certara?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Certara stock analyzed?
Clicking "Analyze stock" lets five strategies assess Certara against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.